DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Rubnitz JE, Inaba H, Dahl G et al.
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.

Lancet Oncol 2010;
11: 543-552

Download Bibliographical Data

Search in:
Access: